microsoft power point_-_bm_exam
DESCRIPTION
TRANSCRIPT
![Page 1: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/1.jpg)
1
Nungruthai Nimnuch
School of Allied Health Sciences
Naresuan University Phayao
Bone Marrow Examination
![Page 2: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/2.jpg)
2
�������� (Bone marrow)
� ������ spongy tissue ������� !�"� ���#$!����%�#&'(�#
� )*���*&+,�-#'./$# #&'(�#/�0!�# 1��.2&� #&'(�# 3�/$3� 4$'�50�,6+�#&!�
� �7!/�0!��� &0!�,1$$8,9:(,$;�(
![Page 3: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/3.jpg)
3
���� �����������������������������
� ,);��<�*27!=!9"�#&-����#!&<&�>?&'>7!�3��!�(0!�.$/+<�+��!���,$;�(<3����!�%9� !9!&=/!27!<�*%(0
� @�0?A��.&2<+(,6;B�*!�6�+(, 9�%�0.(�%9��&!* !,/<5 4<�<&�>(0���+D��;��4$0��3��+�+>E3�.&2%9�%(0
� "60<&�>,);���7! staging 4$'?&'#�*#!&&3#F!@�0?A��.&29',&:�*!�6�+(
� "60 7!/&3*?&',9+�@�0?A�����9�.&2��� lymphoreticular system 4$'�3�"/0#!&�+�+>E3�%9�%(0
� "60<+(<!9&3#F!@�0?A��.&2,$;�( 4$'.&2���&'** lymphoreticularsystem
![Page 4: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/4.jpg)
4
���������������������� ����������!�������� � 3 $ �%
1. "60,�:9,>!'(�( (Aspirtaion) 2. "60,�:9,>!'<3( (Needle Biopsy) 3. #!&<3(%�#&'(�#�!�Q3$�#&&9 (Surgical Biopsy)
���$��������� ��&������������� #&'(�#/�0!�# (Sternum) ����&'/��!�1��.2&���� 2-3� #&'(�# '.)# (Iliac crest) ,>!'<&�*&+,�- Anterior 4$' posterior iliac crest� ?5A9#&'(�# 3�/$3� (Spinous process) ,>!'<&�*&+,�- Anterior 4$' posterior
superior iliac spine� #&'(�#�+,*�� (Tibia)
![Page 5: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/5.jpg)
5
![Page 6: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/6.jpg)
6
��������������� ������'��%� � ?
� #!&,>!'%�#&'(�#>'"60,�$!,)��� 15 �!��
� 4@$���,#+(>!#,�:9���"60,>!'>'9���!(%9�,#+� 2 mm.
� %�#&'(�#���=�#(�(��#9! (bone marrow aspiration) >'=�#�7!%?<&�>�+,2&!'/8 !�"<0#$0��>5$�&&Q�8
� "�*!�2&3B�4)��8>'�7! ������%�#&'(�#��#9!,$:#�0�� .(�#!&"60,�:9��!("/X� ,&��#��! trephine biopsy
![Page 7: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/7.jpg)
7
Bone marrow aspiration
![Page 8: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/8.jpg)
8
�������' �� �'�5��������
� ,>!'4$' ,9��&8�3���
� " � EDTA tube 4$'<3B��+B�%�0?&'9!- 30 �!�� ������%�#&'(�#>'$���\B�9!(0!�*�
�7!#!&(�(%�#&'(�#4$'�7!%? ,9��&8
����� �'�5��������
]Push technique` 4$' ]Pull technique`
Push technique : %= ,9��&8.(�#!&"60 spreader
Pull technique (squash preparation) : "60 glass slide 2 4@��?&'#*#3�4$0�(\���#>!##3�
Fixing and straining aspirate smear
� ,9;�� %$(84/0� 2�&<&\� ,9��&8%�#&'(�#�3���(0�� metanol
� Romanowsky stain : basic dye 4$' acid dye �3B�<��#!&,<&��9 �,#!&#&��, pH ��� staining buffer >'<0��=�#<0�� 4$'&'�',�$!"�#!&�0�9>'�!�#��! ,9��&8,$;�(
93#9�,$;�(?�9!(0��
![Page 9: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/9.jpg)
9
���BC�D�$E���������5�FEE5�����������(Bone marrow examination)
1. Bone marrow smear preparation
2. Bone marrow cellularity
3. ?&+9!- Megakaryocyte
4. M:E ratio
5. Maturation ��� !� myelocytic series 4$' erythrocytic series
6. Megaloblastoid change
7. Histiocyte
8. Plasma cells
9. Eosinophil
10. Blast cells 4$' Metastatic cells
![Page 10: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/10.jpg)
10
1.1 ���������������I�'����E���JE���B�5��� low power field
2�&>')* fat cell 4$' megakaryocyte
��������� �'�5��������������E���'�'���� (Low magnification)
1.2 Bone marrow smear preparation� #!& clot� #!&�0�9 ,9��&8%�#&'(�# : �
Fat cellMegakaryocte
![Page 11: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/11.jpg)
11
1.3 Bone marrow cellularity#!&#&'>!�<3���� nucleated cell "� ,9��&8%�#&'(�# !�"<0 low power field (10X) $3#F-'#!&#&'>!�<3����,1$$89�(3���BNormal cellularity
nucleated cell 9�#!&#&'>!�<3�?&'9!- 2 "� 4 ������);B���� ,9��&8%�#&'(�#���<&�>�+,2&!'/8 !�"<0 low power field
http://bonemarrowbiopsy.wordpress.com/normal-results/
![Page 12: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/12.jpg)
12
Hypocellularity
nucleated cell 9�#!&#&'>!�<3��0��#��! 1 "� 4 ������);B���� ,9��&8%�#&'(�#���<&�>�+,2&!'/8 !�"<0 low power field 1\��$3#F-'��� hypocellularity <&�>)*%(0"�.&2 aplastic anemia, myelofibrosis
www.medscape.com/viewarticle/430138_3
![Page 13: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/13.jpg)
13
Hypercellularity
nucleated cell 9�#!&#&'>!�<3�9!##��! 3 "� 4 ������);B���� ,9��&8%�#&'(�#���<&�>�+,2&!'/8 !�"<0 low power field $3#F-'#!&#&'>!�<3����,1$$84** hypercellularity %(04#� acute leukemia
http://img.medscape.com/fullsize/migrated/501/096/lab501096.fig4.jpg
![Page 14: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/14.jpg)
14
Diluted specimen
!9!&=<&�>)*%(0"�#&-�����3B�<��"�#!&,>!'(�(%�#&'(�#>!#@�0?A��9�#!&?�,?rs�����,$;�(,�0!9!"�<3����!�
+�����<&�>)* !�"<0#$0��>5$�&&Q�8#7!$3���!�<�7! low power field 2;� )* red blood cell ,)+�9�\B�&��9#3*#!&)* fat cell 4$' megakaryocyte ���$($�
![Page 15: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/15.jpg)
15
1.4 ��� �U Megakaryocyte
megakaryocyte ,?t�,1$$8���9���!("/X���� 5(���<&�>)*%(0"�%�#&'(�#
?#<+)* 1-15 cells/LPFMegakaryocyte
![Page 16: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/16.jpg)
16
�����$������5�F��5���FEE5� !��E%��������V���� �'�5��������������W����X�
![Page 17: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/17.jpg)
17
��������� �'�5��������������E���'�'��� (High magnification)1.1 M:E ratio
�3<&! ������ nucleated cell !� myeloid : nucleated cell !� erythroid
2�!?#<+��� normal bone marrow M:E ratio = 3:1
2�&<&�>�3*���!��0�� 10 fields
Myeloid hyperplasia : 9�#!&,)+�9�\B����,1$$8"� !� myeloid
*��*�#��!9�#!&<+(,6;B� (infection)
Erythroid hyperplasia : 9�#!&,)+�9�\B����,1$$8"� !� erythroid
*��*�#��!@�0?A����!>'9� !�'1�( (anemia)
M:E ratio ��
M:E ratio <�7!
![Page 18: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/18.jpg)
18
1.2 Maturation ����' myelocytic series
Normal
,1$$8"� !� myeloid ���)*%(0"� normal bone marrow 2;� ,1$$8"�&'�' metamyelocyte, band form 4$' segmented cell
Shift to the left)*,1$$8<3�����"�&'�' promyelocyte ,)+�99!#�\B�
promyelocyte
metamyelocyte band form segmented cell
![Page 19: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/19.jpg)
19
1.3 Maturation ����' erythroid series
Normal
,1$$8"� !� erythroid ���)*%(0"� normal bone marrow 2;� ,1$$8"�&'�' polychromatic normoblast 4$' orthochromatic normoblast
Shift to the left)*,1$$8<3�����"�&'�' basophilic normoblast
,)+�99!#�\B�
basophilic normoblast
polychromatic normoblast orthochromatic normoblast
![Page 20: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/20.jpg)
20
1.4 Megaloblastoid change
,?t�#!&,?$����4?$����,1$$8"� !� erythroid ,�;���>!##!&�!( �+<!9+� B12 4$' folate �7!"/0�+�,2$�� 9�)3w�!#!&60!#��! ������%1.<)$! 9 1 &'�' 4$',1$$89���!(���"/X�@+(?#<+
http://www.vet.uga.edu/vpp/clerk/Smith/index.php
![Page 21: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/21.jpg)
21
1.5 Histiocyte
� Histiocyte 2;� ,1$$8 Reticuloendothelial cell (RE cell) ���#+�,1$$8,9:( ,$;�(4(�/&;�,9:(,$;�(�;��y���/9(�!�5�3�,�0!%?
� )*%(0"�%�#&'(�#%9�=\� 1% ��� nucleated cell
� )*,)+�9�\B�"�@�0?A�����9�#!&<+(,6;B� (infection) .(�>')*&��9#3* plasma cell 4$' eosinophil
_Rhopheocytosisa 2;� ?&!#{#!&-8���,1$$8 histiocyte 9�,1$$8,9:(,$;�(4(�<3�����.(�,E)!',1$$8 polychromatic normoblast >7!���9!#9!$0�9&�*,);��(�(13*,/$:#>!#,1$$8 histiocyte
Reactive histiocyte
![Page 22: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/22.jpg)
22
Plasma cell
1.6 Plasma cells� Plasma cell 9�$3#F-'�+�,2$�� ,?t�&�?%��4$'93#>'����6+(��*(0!�"(
(0!�/�\�����,1$$8 (eccentric) %1.<)$! 92$0!�|���B7!(spongy)�)*%(0"�%�#&'(�#%9�=\� 1% ��� nucleated cell�)*,)+�9�\B�"�@�0?A�����9�#!&<+(,6;B� (infection)�#!&)* plasma cell �3B�<3�����4$'<3�4#�,)+�99!#�\B�"�%�#&'(�#
!9!&=*��6�B=\�.&29',&:�6�+( Multiple myeloma (MM)1\��@�0?A��9�#!& &0!� monoclonal immunoglobulin (MoIg) ���\B����!�@+(?#<+
�MoIg ,&��#��! M-protein /&;� paraprotein 1\��>'9�&'(3* ���\B��3B�"�,$;�(4$'"�?} !�'���@�0?A��
![Page 23: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/23.jpg)
23
1.7 Eosinophil� "�%�#&'(�#?#<+>')* eosinophil %(0 1-5% ��� nucleated cell �������"�%�#&'(�#
� ?&+9!-��� eosinophil ���,)+�9�\B��\B�#��!?#<+ !9!&=)+>!&-!%(0(3���B
~ Infection 93#>')* eosinophil ,)+�9�\B�"� !�' infection &��9#3*#!&,)+�9�\B���� histiocyte 4$' plasma cell
~ CML "�@�0?A��9',&:�,9:(,$;�(�!�6�+( Chronic Myelocytic Leukemia 93#>')* eosinophil ,)+�9 ���\B�(0��
~ "60"�#!&<+(<!9@$#!&&3#F!/$3�>!#%(0&3*#!&&3#F!(0���!,29�4$0� .(�>'<0���&!*?&'�3<+���@�0?A��#���#!& treatment /!#9�#!&<�* ���<��#!&&3#F!>')* eosinophil ���,)+�9�\B�&��9#3*#!&9�,1$$8<3��������$($�4$',1$$8,&+�99�#!& differentiation ,#+(�\B� !9!&=*��*�#%(0��!@�0?A��9��!#!&(��\B� (Well recovery)
Eosinophil
![Page 24: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/24.jpg)
24
1.8 Blast cells
� "�%�#&'(�#?#<+ !9!&=<&�>)* blast cell %(0%9�,#+� 3% ��� nucleated cell
� blast cell > 30% leukemia?Pronormoblast
Myeloblast
Lymphoblast
Monoblast
![Page 25: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/25.jpg)
25
1.9 Metastatic cells
2;� ,1$$89',&:����,#+(>!#��3��'�;��4$'9�#!&$5#$!9 (metastasis) >!#��3��'���,?t�9',&:�9!�3�%�#&'(�#
http://www.healthsystem.virginia.edu/internet/hematology/hessidb/Rare-bone-marrow-findings.cfm
Metastatic cells
![Page 26: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/26.jpg)
26
![Page 27: Microsoft power point_-_bm_exam](https://reader033.vdocument.in/reader033/viewer/2022051816/54734321b4af9fa90a8b5192/html5/thumbnails/27.jpg)
27